The treatment of severe malaria.
In the SEAQUAMAT trial, parenteral artesunate was shown to be associated with a considerably lower mortality than quinine, and is now the recommended treatment for severe malaria in low-transmission areas and in the second and third trimesters of pregnancy. A trial is underway to establish its role...
Päätekijät: | Dondorp, A, Day, N |
---|---|
Aineistotyyppi: | Journal article |
Kieli: | English |
Julkaistu: |
2007
|
Samankaltaisia teoksia
-
The management of patients with severe malaria.
Tekijä: Day, N, et al.
Julkaistu: (2007) -
The treatment of severe malaria
Tekijä: Dondorp, A
Julkaistu: (2007) -
UK recommendations for severe malaria are worrying.
Tekijä: White, N, et al.
Julkaistu: (2007) -
Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial.
Tekijä: Dondorp, A, et al.
Julkaistu: (2005) -
Artesunate dosing in severe falciparum malaria.
Tekijä: Dondorp, A, et al.
Julkaistu: (2012)